THRODAHL MARK C (President and CEO) sold 1.7% of their position (2.43K shares) of ORTHOPEDIATRICS CORP on the open market
Open‑market sale worth $67.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/12/2024ACC: 0001425450-24-000022
DirectorOfficer· President and CEO
Since Feb 2019
-2.43K
Net shares
Net seller
$67.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.43K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.43K
Price / share
$27.59
Trade value
$67.13K
% of position
1.7%
3/11/2024
140.29K→137.86K
Total
Net shares
−2.43K
Net value
-$67.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | S · Sale | −2.43K | $27.59 | $67.13K | 1.7% | 140.29K | 137.86K |
| Total | −2.43K | -$67.13K | ||||||
Derivative Transactions0
No derivative transactions reported